Home SalvaRx Group

SalvaRx Group

In operation
IPO
Developer of Novel Cancer Immunotherapies
Basic
Enterprise Profile

Basic Information

SalvaRx Group PLC, formerly known as 3Legs Resources plc, was established in 2007 as a company focused on immuno-oncology and investing in novel cancer immunotherapy drugs.
SalvaRx Group PLC
England,United Kingdom
15~50 people
January 01, 2007
http://www.3legsresources.com/
--

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy Biological Drug Production
Technology
Genetic Testing Genetic Engineering Immunological Techniques Cell Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Biologics Innovative Drugs